A detailed history of Vanguard Group Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,454,288 shares of AKYA stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,454,288
Previous 1,408,157 3.28%
Holding current value
$3.4 Million
Previous $6.87 Million 0.74%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.33 - $6.06 $199,747 - $279,553
46,131 Added 3.28%
1,454,288 $6.82 Million
Q4 2023

Feb 14, 2024

BUY
$3.13 - $5.13 $180,795 - $296,319
57,762 Added 4.28%
1,408,157 $6.87 Million
Q3 2023

Nov 14, 2023

BUY
$4.24 - $7.44 $174,963 - $307,011
41,265 Added 3.15%
1,350,395 $6.28 Million
Q2 2023

Aug 14, 2023

BUY
$5.28 - $8.35 $1.7 Million - $2.68 Million
321,357 Added 32.53%
1,309,130 $9.67 Million
Q1 2023

May 15, 2023

BUY
$7.6 - $12.68 $305,109 - $509,051
40,146 Added 4.24%
987,773 $8.08 Million
Q4 2022

Feb 10, 2023

BUY
$8.6 - $14.1 $220,048 - $360,776
25,587 Added 2.78%
947,627 $9.07 Million
Q3 2022

Nov 14, 2022

BUY
$10.63 - $15.76 $1.5 Million - $2.22 Million
141,017 Added 18.06%
922,040 $10.8 Million
Q2 2022

Aug 12, 2022

BUY
$8.38 - $12.85 $672,076 - $1.03 Million
80,200 Added 11.44%
781,023 $10 Million
Q1 2022

May 13, 2022

BUY
$9.84 - $14.97 $254,314 - $386,899
25,845 Added 3.83%
700,823 $7.7 Million
Q4 2021

Feb 14, 2022

BUY
$11.37 - $15.31 $3.72 Million - $5.01 Million
327,323 Added 94.15%
674,978 $10.3 Million
Q3 2021

Nov 12, 2021

BUY
$13.04 - $21.0 $35,468 - $57,120
2,720 Added 0.79%
347,655 $4.85 Million
Q2 2021

Aug 13, 2021

BUY
$17.89 - $26.05 $6.17 Million - $8.99 Million
344,935 New
344,935 $6.67 Million

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $88.7M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.